Etravirine TMC-125 CAS 269055-15-4 Intende ≥99.0% (HPLC) API Factory High Purity Featured Image

Etravirine TMC-125 CAS 269055-15-4 Intende ≥99.0% (HPLC) API Factory High Munditia

Description:

Nomen chemicum: Etravirine (TMC-125)

CAS: 269055-15-4

Aspectus: solidum album pulveris

Dic: ≥99.0% (HPLC)

Inhibitor (NNRTI) usus est pro curatione HIV.

API High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio:

Manufacturer cum High puritate et stabulo Quality
Chemical Name: Etravirine (TMC-125)
CAS: 269055-15-4
API High Quality, Commercial Production

Chemical Properties:

Nomen chemicum	Etravirina
Synonyma	TMC-125
CAS Number	269055-15-4
CATTUS Number	RF-API54
Stock Status	In Stock, Productio Ascendite ad Tons
Formulae hypotheticae	C20H15BrN6O
M. Pondus	435.28
Density	1.439 g/cm3
Shipping Condition	Sub Ambient Temperature
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Aspectus	solidus albus pulveris
Lepidium sativum	Per IR, HPLC
Liquescens punctum	211.0~216.0℃
Aqua Content	≤0.50%
Residere in Ignition	≤0.20%
Metalla gravis	≤20ppm
Unam immunditiam	≤0.50%
Totalis immunditias	≤1.0%
Assay	≥99.0% (HPLC)
Test Standard	Enterprise Standard

Sarcina & Repono:

sarcina: Utrem, aluminium foil, pera, cardboard tympanum, 25kg/Drum, vel secundum exigentiam emptoris.

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, humore et pestis infestatione.

commoda:

FAQ:

Applicatio:

Etravirina (TMC-125) (CAS 269055-15-4) secunda generatio non-nucleoside transversa transcriptase inhibitor (NNRTI) adhibita est ad curationem HIV.Indicatur usus in compositione cum aliis agentibus antiretroviralibus ad infectionem HIV-1 tractandi in aegros adultos peritos qui testimonium viralis replicationis et modi HIV-1 resistunt in promptu NNRTIs et aliis agentibus antiretroviralibus.NNRTIs, una cum inhibitoribus nucleotide/nucleotide inversa transcriptase (NRTIs/NtRTIs), momenti sunt elementa compositionis diaetam quae nunc tractant HIV-1 infectio adhibita.Actus NRTIs/NtRTIs contendendo cum nucleotide naturali subiectae transpositae e contrariis ad incorporationem in DNA viralem et catenam terminationem subsequentem.E contra, NNRTIs ad allostericum enzyme situm obligant et functionem polymerasin DNA perturbant inducendo mutationes conformationales ad locum catalyticum.